Humberto Graner Moreira

Humberto Graner Moreira

Auto-generated profile, based on publicly available information

Humberto Graner Moreira

Universidade Federal de Goiás

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2018 in BMC Public Health
Verified
Journal Article
Open access
PDF file
ARAna Carolina Rezende
Ana Carolina Rezende
LSLudimila Garcia Souza
Ludimila Garcia Souza
TJThiago Veiga Jardim
Thiago Veiga Jardim
NPNaiana Borges Perillo
Naiana Borges Perillo
YAYmara Cássia Luciana Araújo
Ymara Cássia Luciana Araújo
PJPaulo César Brandão Veiga Jardim
Paulo César Brandão Veiga Jardim
The best anthropometric indicator to verify the association between obesity and hypertension (HTN) has not been established. We conducted this study to evaluate and compare the discriminatory power of waist-to-height ratio (WHtR) in relation to body mass index (BMI) and waist circumference (WC) in predicting HTN after 13 years of follow-up. This study was an observational prospective cohort study performed in the city of Firminópolis, in Brazilian’s midwest. The cohort baseline (phase 1) was initiated in 2002 with the evaluation of a representative sample of the normotensive population (≥ 18 years of age). The incidence of HTN was evaluated as the outcome (phase 2). Sociodemographic, dietary and lifestyle variables were used to adjust proportional hazards models and evaluate risk of HTN according to anthropometric indices. The areas under the receiver operating characteristic (ROC) curves were used to compare the predictive capacity of these indices. The best HTN predictor cut-offs were obtained based on sensitivity and specificity. A total of 471 patients with a mean age of 38.9 ± 12.3 years were included in phase 1. The mean follow-up was 13.2 years, and 207 subjects developed HTN. BMI, WC and WHtR were associated with risk of HTN incidence and had similar power in predicting the disease. However, the associations were only significant for women. The cut-off points with a better HTN predictive capacity were in agreement with current recommendations, except for the WC in men. The results suggest that both overall obesity (BMI) and central obesity (WC and WHtR) anthropometric indicators can be used in this population to evaluate the risk of developing hypertension.

13 October 2025 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
FRFabiana Hanna Rached
Fabiana Hanna Rached
MMMarcio Hiroshi Miname
Marcio Hiroshi Miname
VRViviane Zorzanelli Rocha
Viviane Zorzanelli Rocha
AZAndré Zimerman
André Zimerman
FCFernando Henpin Yue Cesena
Fernando Henpin Yue Cesena
JSJose Saraiva
Jose Saraiva

19 April 2017 in Clinical Science
Verified
Journal Article
Closed access
PDF file
HMHumberto G. Moreira
Humberto G. Moreira
RLRony L. Lage
Rony L. Lage
DMDaniel G. Martinez
Daniel G. Martinez
LFLarissa Ferreira-Santos
Larissa Ferreira-Santos
MRMaria U.P.B. Rondon
Maria U.P.B. Rondon
JNJosé Nicolau
José Nicolau
Previous studies have shown that both sympathetic hyperactivity and enhanced inflammatory responses are associated with poor outcomes in patients with acute coronary syndrome (ACS). Whether there is a correlation between these two characteristics remains unclear. Thirty-four patients with uncomplicated ACS were evaluated; their mean age was 51.7±7.0 years, 79.4% were male, and 94.1% had myocardial infarction (MI). On the fourth day of hospitalization, they underwent muscle sympathetic nerve activity (MSNA) analysis (microneurography), as well as ultrasensitive C-reactive protein (usCRP), interleukin-6 (IL-6), and lipoprotein-associated phospholipase A2 (Lp-PLA2) activity measurements. These evaluations were repeated at 1, 3, and 6 months after hospitalization. Both MSNA and inflammatory biomarkers were elevated during the acute phase of ACS and then decreased over time. At hospitalization, the median usCRP level was 17.75 (IQR 8.57; 40.15) mg/l, the median IL-6 level was 6.65 (IQR 4.45; 8.20), the mean Lp-PLA2 activity level was 185.8 ±52.2 nmol/min per ml, and mean MSNA was 64.2±19.3 bursts/100 heart beats. All of these variables decreased significantly over 6 months compared with the in-hospital levels. MSNA was independently associated with the peak level of creatine kinase isoenzyme MB (CKMB) in the acute phase (P=0.027) and with left ventricular ejection fraction (LVEF) at 6 months (P=0.026). Despite the increased levels of inflammatory biomarkers and sympathetic hyperactivity in the initial phase of ACS, no significant correlations between them were observed in any of the analyzed phases. Our data suggest that although both sympathetic hyperactivity and inflammation are concomitantly present during the early phase of ACS, these characteristics manifest via distinct pathological pathways.

15 January 2018 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
LSLudimila Garcia Souza
Ludimila Garcia Souza
TJThiago Veiga Jardim
Thiago Veiga Jardim
ARAna Carolina Rezende
Ana Carolina Rezende
ASAna Luiza Lima Sousa
Ana Luiza Lima Sousa
HMHumberto Graner Moreira
Humberto Graner Moreira
PJPaulo César Brandão Veiga Jardim
Paulo César Brandão Veiga Jardim
Obesity is a chronic complex disease with an increasing prevalence around the world. Prospective studies in adult cohorts are needed to provide information about predictors of new-onset overweight/obesity on population-based levels. The aim of this study was to identify factors associated with the risk of an adult individual become overweight/obese after 13 years of follow-up. Second phase of an observational population-based prospective cohort study in a small town in the Midwest region of Brazil. A representative sample of the adult population (≥18 years) was assessed in 2002 (phase 1). Anthropometric, sociodemographic, dietary intake and lifestyle data were collected. After 13 years of follow-up (2015), the same variables were re-evaluated (phase 2). New-onset overweight/obesity was the outcome variable. A total of 685 subjects were included with a mean age in phase 1 of 42.7 ± 13.8 years and 56.1 ± 13.8 years in phase 2, the mean follow-up time was 13.2 years and female sex counted for 66.3% of the sample. Total weight gain was 5.9 ± 10.2 Kg, body mass index increased 2.6 ± 3.8 Kg/m2 and waist circumference (WC) values increased 8.0 ± 10.5 cm. The prevalence of overweight/obesity went from 49.1% in phase 1 to 69.8% in phase 2 (p < 0.001). The factors associated with a decreased risk of new-onset overweight/obesity were ages between 50 and 64 (RR 0.40; CI 0.24–0.67 – p = 0.001) and ≥65 years (RR 0.15; CI 0.06–0.35 - p < 0.001), being part of the second quartile of fat consumption (RR 0.59; CI 0.35–0.97 – p = 0.041), no alcohol consumption (RR 0.59; CI 0.37–0.93 – p = 0.024) and smoking (RR 0.58; CI 0.39–0.86 – p = 0,007) in phase 1. We identified in thirteen years of follow-up that older ages, a moderate fat consumption compared to low consumption, no alcohol consumption and smoking habit were related to a decreased risk of new-onset overweight/obesity. Obesity prevention actions must focus on subjects at younger ages and include policies to reduce alcohol consumption.

1 August 2004 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
Antonio da Silva Menezes JuniorAntonio da Silva Menezes Junior
Antonio da Silva Menezes Junior
HMHumberto Graner Moreira
Humberto Graner Moreira
MDMurilo Tavares Daher
Murilo Tavares Daher
OBJETIVO: Comparar a variabilidade de freqüência cardíaca em indivíduos normotensos e hipertensos e observar o comportamento do sistema nervoso autônomo após terapia com inibidores da enzima conversora de angiotensina II. MÉTODO: Estudados 286 pacientes com diagnóstico de hipertensão arterial, pela 1ª vez, e divididos em 4 grupos, conforme a pressão arterial diastólica (PAD): grupo A - PAD110 mmHg. Os pacientes do grupo A (normais) e do grupo C (HA moderada), somando 110 e 79 pacientes, respectivamente, submeteram-se ao Holter-ECG 24h com análise de variabilidade de freqüência cardíaca no domínio do tempo (DT) e no domínio da freqüência (DF). O grupo C foi tratado com inibidores da ECA durante 3 meses, e após esse período novamente avaliado com Holter-ECG 24h e variabilidade da freqüência cardíaca, e os valores comparados com os normotensos. RESULTADOS: Os parâmetros SDNN, PNN50 (DT) e o espectro LF (DF) foram significativamente diferentes para os dois grupos, com valores notadamente diminuídos em hipertensos (p110 mmHg. Group A (110 healthy individuals) and group C (79 patients with moderate AH) underwent 24-hour Holter-ECG with analysis of heart rate variability in time domain (TD) and frequency domain (FD). The group C patients were treated with ACE inhibitors for 3 months, and, after this period, they underwent a new 24-hour Holter-ECG study for assessing heart rate variability, the values being compared with those of normotensive individuals. RESULTS: The SDNN and PNN50 parameters (TD), and the LF spectrum (FD) were significantly different in the 2 groups, with clearly reduced values in hypertensive individuals (P<0.05). Group C patients, after treatment with ACE inhibitors, showed a recovery in all variables of heart rate variability, achieving values close to those of normotensive individuals. CONCLUSION: Heart rate variability was reduced in hypertensive patients when compared with that in normotensive individuals, indicating a decrease in the baroreceptor reflex. A functional autonomic adjustment after the antihypertensive treatment with ACEI was observed, indicating recovery of parasympathetic tonus

7 April 2022 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
HMHumberto Graner Moreira
Humberto Graner Moreira
MOMúcio Tavares de Oliveira
Múcio Tavares de Oliveira
BVBruno Pereira Valdigem
Bruno Pereira Valdigem
CMCristiane Nunes Martins
Cristiane Nunes Martins
CPCarisi Anne Polanczyk
Carisi Anne Polanczyk
Introdução O Comitê Científico da Sociedade Brasileira de Cardiologia, por determinação do seu Conselho Administrativo, convocou em grupo de trabalho para monitorar e organizar, de forma continuada e sistemática, evidências científicas da segurança cardiovascular das vacinas contra COVID-19. O objetivo desse grupo de trabalho é reproduzir dados cientificamente sólidos, sintetizar a evidência no momento disponível, e oferecer recomendações para o cardiologista brasileiro na forma de posicionamentos da SBC. As vacinas para prevenir a infecção por SARS-CoV-2 são consideradas a abordagem [...] Introdução O Comitê Científico da Sociedade Brasileira de Cardiologia, por determinação do seu Conselho Administrativo, convocou em grupo de trabalho para monitorar e organizar, de forma continuada e sistemática, evidências científicas da segurança cardiovascular das vacinas contra COVID-19. O objetivo desse grupo de trabalho é reproduzir dados cientificamente sólidos, sintetizar a evidência no momento disponível, e oferecer recomendações para o cardiologista brasileiro na forma de posicionamentos da SBC. As vacinas para prevenir a infecção por SARS-CoV-2 são consideradas a abordagem